OpenDNA
AI platform for genetically personalized medicine of chronic multi-gene diseases, focusing on hypertension.
About
Technology stack
detected 2026-06-18No comments yet. Be the first to share your take.
What does OpenDNA do?
OpenDNA is developing an artificial intelligence platform designed for genetically personalized medicine, specifically targeting chronic multi-gene diseases. Their platform aims to empower physicians to prescribe the most genetically suitable treatments to patients at the point of care. The company's initial focus is on hypertension, also known as the silent killer.
How much funding has OpenDNA raised?
OpenDNA has raised a total of $1M in funding. The most recent round on record is Seed.
Where is OpenDNA headquartered?
OpenDNA is headquartered in San Diego, United States.
When was OpenDNA founded?
OpenDNA was founded in 2017.
What industry does OpenDNA operate in?
OpenDNA operates in Hypertension, Healthcare, Point of care, Genomics, HealthTech, MedTech.